These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26713557)

  • 21. A missense mutation in the sodium channel β1b subunit reveals SCN1B as a susceptibility gene underlying long QT syndrome.
    Riuró H; Campuzano O; Arbelo E; Iglesias A; Batlle M; Pérez-Villa F; Brugada J; Pérez GJ; Scornik FS; Brugada R
    Heart Rhythm; 2014 Jul; 11(7):1202-9. PubMed ID: 24662403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
    Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
    Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A.
    Kanters JK; Yuan L; Hedley PL; Stoevring B; Jons C; Bloch Thomsen PE; Grunnet M; Christiansen M; Jespersen T
    Circ J; 2014; 78(5):1136-43. PubMed ID: 24599044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Molecular genetics of the long QT syndrome: clinical aspects].
    Sepp R; Csanády M
    Orv Hetil; 1999 Nov; 140(47):2633-8. PubMed ID: 10613047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac sodium channel mutation associated with epinephrine-induced QT prolongation and sinus node dysfunction.
    Chen J; Makiyama T; Wuriyanghai Y; Ohno S; Sasaki K; Hayano M; Harita T; Nishiuchi S; Yuta Yamamoto ; Ueyama T; Shimizu A; Horie M; Kimura T
    Heart Rhythm; 2016 Jan; 13(1):289-98. PubMed ID: 26282245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
    Turker I; Ai T; Itoh H; Horie M
    Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of Nedd4-2-binding capacity in PY-motif of Na
    Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Tale of 2 Diseases: The History of Long-QT Syndrome and Brugada Syndrome.
    Havakuk O; Viskin S
    J Am Coll Cardiol; 2016 Jan; 67(1):100-8. PubMed ID: 26764071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of Cardiac Sodium Channel β-Subunit Variants to Brugada Syndrome.
    Peeters U; Scornik F; Riuró H; Pérez G; Komurcu-Bayrak E; Van Malderen S; Pappaert G; Tarradas A; Pagans S; Daneels D; Breckpot K; Brugada P; Bonduelle M; Brugada R; Van Dooren S
    Circ J; 2015; 79(10):2118-29. PubMed ID: 26179811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential thermosensitivity in mixed syndrome cardiac sodium channel mutants.
    Abdelsayed M; Peters CH; Ruben PC
    J Physiol; 2015 Sep; 593(18):4201-23. PubMed ID: 26131924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Arrhythmias Related to Sodium Channel Dysfunction.
    Savio-Galimberti E; Argenziano M; Antzelevitch C
    Handb Exp Pharmacol; 2018; 246():331-354. PubMed ID: 28965168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long QT syndrome].
    Nakajima T; Kaneko Y; Taniguchi Y; Nagai R
    Nihon Rinsho; 1996 Mar; 54(3):776-81. PubMed ID: 8904236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Classification of Brugada Syndrome-Associated and Long-QT Syndrome-Associated Genetic Variants in the SCN5A-Encoded Na(v)1.5 Cardiac Sodium Channel.
    Kapplinger JD; Giudicessi JR; Ye D; Tester DJ; Callis TE; Valdivia CR; Makielski JC; Wilde AA; Ackerman MJ
    Circ Cardiovasc Genet; 2015 Aug; 8(4):582-95. PubMed ID: 25904541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of pharmacotherapy in cardiac ion channelopathies.
    El-Sherif N; Pedalino R; Himel H
    Curr Vasc Pharmacol; 2009 Jul; 7(3):358-66. PubMed ID: 19601860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.